Corpus ID: 39272774

Breast Augmentation by The Effect of Phytoestrogen

  title={Breast Augmentation by The Effect of Phytoestrogen},
  author={J. Chung},
The phytoestrogen has the positive effect in osteoporosis, cardiovascular diseases, facial flushing and other postmenopausal symptoms. And the purpose of this study was to evaluate the effect of phytoestrogen in increasing breast size clinically and histological. The result show meaningful augmentation of the breast in group taken phytoestrogen tablets (PEITO) and in mouse study, study group showed more lobules and more duct cells in lobules than control group histological. The results mean… Expand

Figures and Tables from this paper

Effects of Tested Pack Containing Plant Extracts on Elasticity and Size of Women’s Breasts
Excesses leading to cell growth and fat accumulation in adipocytes can effectively contribute to improving the elasticity and size of women’s breasts. Expand


Phytoestrogens: pharmacological and therapeutic perspectives.
This review analyzes, on the basis of available experimental and epidemiological studies, the pros and cons of phytoestrogen use and describes the potential tissue targets and mechanisms of action of phYtoestrogens. Expand
Phytoestrogens in the Management of the Menopause:: Up-To-Date
  • A. Ewies
  • Medicine
  • Obstetrical & gynecological survey
  • 2002
Clinical applications for phytoestrogens are still in their infancy, and more interventional trials are required to reach definitive conclusions regarding their efficacy and safety, although they appear to represent a promising group of compounds, which may be useful in the future for the treatment of the menopausal syndrome. Expand
Phytoestrogen and breast cancer prevention.
  • O. Ganry
  • Medicine
  • European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation
  • 2002
Most epidemiologic studies have involved Asian populations and some studies have shown a substantial reduction in breast-cancer risk in these populations, but these results were also observed in countries where the level of consumption of traditional soy foods is low. Expand
Phytoestrogens for hormone replacement therapy?
Evidence is now available that the yet unknown compounds in Cimicifuga racemosa extracts prevent climacteric complaints and may also have antiosteoporotic effects. Expand
Potential risks and benefits of phytoestrogen-rich diets.
  • A. Cassidy
  • Biology, Medicine
  • International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition
  • 2003
The limited studies conducted so far in humans clearly confirm that soya isoflavones can exert hormonal effects, and further clinical studies are necessary to determine the potential health effects of these compounds in specific population groups. Expand
Clinical Effects of Phytoestrogens
The phytoestrogens seem to possess agonist and antagonist properties resembling selective estrogen-receptor modulators and may be related to their preferential binding and activity at these two types of receptors. Expand
Phytoestrogens: recent developments.
Since phytoestrogens are structurally very similar to the estrogen 17beta-estradiol, they may exhibit selective estrogen receptor modulating activities, and special attention will be given to the hormonal effects of various isoflavonoids, including genistein, daidzein, coumestrol and equol, several prenylated flavonoid, especially 8-prenylnaringenin, and the stilbene resveratrol. Expand
Oral contraceptive use influences resting breast proliferation.
Recognition is given to acknowledging the multiple factors and interactive processes responsible for breast epithelial stimulation when considering strategies of intervention for oral contraceptive use and breast cancer risk. Expand
Hormonal breast augmentation: prognostic relevance of insulin-like growth factor-I.
IGF-I concentration seems to be of prognostic value as far as the response of breast tissue to estrogen stimulation is concerned, and if IGF-I levels do not increase within 1 month, treatment should be discontinued, and this indicates that treatment is likely to be successful and can therefore be continued. Expand
Proliferative response of mammary glandular tissue to formononetin.
The results demonstrate the ability of formononetin to support mammary gland proliferation, but the estrogenic potency appears extremely weak compared with that of estradiol-17 beta and is roughly proportional to estrogen receptor-binding capacity. Expand